The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis
Autor: | Andrew Purcell, Mohammed A. Yousef, Mohamed Gomaa Kamel, Amr Naguib, Mohamed Wagih, Hany Mahmoud Yassin, Ehab Farag, Mohamed Helmy, Mohamed Elayashy, Fatma Abd-Elshahed Abd-Elhay, Haytham Zien Algameel, Mohamed Hamza, Ahmed Abdelaal Ahmed Mahmoud M Alkhatip |
---|---|
Rok vydání: | 2021 |
Předmět: |
Adult
Male 0301 basic medicine Oncology medicine.medical_specialty Coronavirus disease 2019 (COVID-19) Neutrophils Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Sensitivity and Specificity Severity of Illness Index Pathology and Forensic Medicine Leukocyte Count 03 medical and health sciences 0302 clinical medicine Internal medicine Severity of illness Genetics medicine Humans In patient Lymphocyte Count Neutrophil to lymphocyte ratio Molecular Biology Aged business.industry fungi Advanced stage COVID-19 Middle Aged Prognosis Neutrophil-to-lymphocyte ratio – covid-19 – coronavirus – diagnosis – prognosis – systematic review – meta-analysis 030104 developmental biology 030220 oncology & carcinogenesis Meta-analysis Molecular Medicine Biomarker (medicine) Female business Research Article Meta-Analysis |
Zdroj: | Expert Review of Molecular Diagnostics article-version (VoR) Version of Record |
ISSN: | 1744-8352 1473-7159 |
DOI: | 10.1080/14737159.2021.1915773 |
Popis: | Background: The world urgently requires surrogate markers to diagnose COVID-19 and predict its progression. The severity is not easily predicted via currently used biomarkers. Critical COVID‐19 patients need to be screened for hyperinflammation to improve mortality but expensive cytokine measurement is not routinely conducted in most laboratories. The neutrophil-to-lymphocyte ratio (NLR) is a novel biomarker in patients with various diseases. We evaluated the diagnostic and prognostic accuracy of the NLR in COVID-19 patients. Methods: We searched for relevant articles in seven databases. The quantitative analysis was conducted if at least two studies were evaluating the NLR role in COVID-19. Results: We included 8,120 individuals, including 7,482 COVID-19 patients, from 32 articles. Patients with COVID-19 had significantly higher levels of NLR compared to negative individuals. Advanced COVID-19 stages had significantly higher levels of NLR than earlier stages. Expert Opinion: We found significantly higher levels of NLR in advanced stages compared to earlier stages of COVID-19 with good accuracy to diagnose and predict the disease outcome, especially mortality prediction. A close evaluation of critical SARS-CoV-2 patients and efficient early management are essential measures to decrease mortality. NLR could help in assessing the resource allocation in severe COVID-19 patients even in restricted settings. |
Databáze: | OpenAIRE |
Externí odkaz: |